Use of Hancock porcine xenografts in children and adolescents.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 7415989)

Published in Am J Cardiol on September 01, 1980

Authors

S P Sanders, R J Levy, M D Freed, W I Norwood, A R Castaneda

Articles citing this

Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol (1983) 1.37

Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization. Am J Pathol (1986) 1.09

The role of glutaraldehyde-induced cross-links in calcification of bovine pericardium used in cardiac valve bioprostheses. Am J Pathol (1987) 1.06

Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol (1999) 0.96

Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification. Ann Thorac Surg (2011) 0.86

Degeneration and calcification of bioprosthetic cardiac valves. Bioprosthetic tricuspid valve implantation in sheep. Am J Pathol (1982) 0.80

Heart valve replacement. Arch Dis Child (1985) 0.75

The effects of the covalent attachment of 3-(4-hydroxy-3,5-di-tert-butylphenyl) propyl amine to glutaraldehyde pretreated bovine pericardium on structural degeneration, oxidative modification, and calcification of rat subdermal implants. J Biomed Mater Res A (2014) 0.75

Late results of mitral valve replacement using unstented antibiotic sterilised aortic homografts. Br Heart J (1983) 0.75

Repair of congenital malformations of the mitral valve in children: early and long-term results in 34 cases. Tex Heart Inst J (1989) 0.75

Biological artificial valve dysfunction - single-centre, observational echocardiographic study in patients operated on before age 65 years. Arch Med Sci (2011) 0.75

Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction. J Am Heart Assoc (2017) 0.75

Articles by these authors

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med (1991) 5.22

The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49

Monitoring for anthracycline cardiotoxicity. Pediatrics (1994) 4.05

Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med (1995) 4.03

Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation (1997) 3.38

Baffle fenestration with subsequent transcatheter closure. Modification of the Fontan operation for patients at increased risk. Circulation (1990) 3.35

Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation (1998) 2.97

Clinical auscultation skills in pediatric residents. Pediatrics (2000) 2.61

Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis (1999) 2.56

Physiologic repair of aortic atresia-hypoplastic left heart syndrome. N Engl J Med (1983) 2.50

The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res (1997) 2.28

Two-dimensional echocardiographic findings in double orifice mitral valve. J Am Coll Cardiol (1985) 2.23

Tetralogy of Fallot [S,D,I]: successful repair without a conduit. Ann Thorac Surg (1995) 2.22

Neonatal critical valvar aortic stenosis. A comparison of surgical and balloon dilation therapy. Circulation (1989) 2.18

Outcome and assessment after the modified Fontan procedure for hypoplastic left heart syndrome. Circulation (1992) 2.15

Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol (2000) 2.14

Sinus venosus defects: unroofing of the right pulmonary veins--anatomic and echocardiographic findings and surgical treatment. Am Heart J (1994) 2.12

Clinical outcomes after the arterial switch operation for transposition. Patient, support, procedural, and institutional risk factors. Congenital Heart Surgeons Society. Circulation (1992) 2.08

Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res (1996) 2.05

Refinement of the alpha aminooleic acid bioprosthetic valve anticalcification technique. Ann Thorac Surg (1997) 2.05

Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation (1978) 1.97

Infundibular septal resection: surgical anatomy of the superior approach. J Thorac Cardiovasc Surg (1988) 1.93

Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med (1992) 1.92

Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation (1992) 1.90

Interrupted aortic arch in infancy. J Pediatr (1976) 1.83

ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis (1998) 1.83

Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease. Circulation (1981) 1.76

Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, April 28-May 2, 1999. Tissue heart valves: current challenges and future research perspectives. J Biomed Mater Res (1999) 1.73

Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol (1992) 1.72

Experience with operations for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg (1981) 1.71

Surgical experience with thirteen conjoined twins. Ann Surg (1988) 1.70

Predictors of survival in neonates with critical aortic stenosis. Circulation (1991) 1.68

Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation (1994) 1.65

Patterns of anomalous pulmonary venous connection/drainage in hypoplastic left heart syndrome: diagnostic role of Doppler color flow mapping and surgical implications. J Am Coll Cardiol (1992) 1.58

Pulmonary artery sling: primary repair by tracheal resection in infancy. J Thorac Cardiovasc Surg (1989) 1.56

Hypoplastic left heart syndrome: experience with palliative surgery. Am J Cardiol (1980) 1.55

Results of routine preoperative coronary angiography in tetralogy of Fallot. Circulation (1975) 1.54

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (1994) 1.52

Fetal echocardiography. Radiol Clin North Am (1990) 1.51

Rapid two-stage arterial switch operation. Acquisition of left ventricular mass after pulmonary artery banding in infants with transposition of the great arteries. Circulation (1994) 1.49

Echocardiographic and anatomic findings in atrioventricular discordance with ventriculoarterial concordance. Am J Cardiol (1988) 1.47

Diagnosis of coronary artery anatomy by two-dimensional echocardiography in patients with transposition of the great arteries. Circulation (1987) 1.46

Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat Biotechnol (2000) 1.46

Preoperative risk-of-death prediction model in heart surgery with deep hypothermic circulatory arrest in the neonate. J Thorac Cardiovasc Surg (2000) 1.46

Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation (1981) 1.46

Anomalous origin of left coronary artery from pulmonary artery. Ligation versus establishment of a two coronary artery system. J Thorac Cardiovasc Surg (1987) 1.45

Prospective detection by Doppler color flow imaging of additional defects in infants with a large ventricular septal defect. J Am Coll Cardiol (1990) 1.45

Hypoplastic left heart syndrome: hemodynamic and angiographic assessment after initial reconstructive surgery and relevance to modified Fontan procedure. J Am Coll Cardiol (1991) 1.45

Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg (1997) 1.41

Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study. Circulation (1995) 1.41

Reduction in levels of triiodothyronine following the first stage of the Norwood reconstruction for hypoplastic left heart syndrome. Cardiol Young (2001) 1.39

Factors associated with marked reduction in mortality for Fontan operations in patients with single ventricle. J Thorac Cardiovasc Surg (1992) 1.39

Transposition of the great arteries with posterior aorta. Anatomic repair. J Thorac Cardiovasc Surg (1990) 1.38

Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol (1983) 1.37

Transposition of the great arteries and intact ventricular septum: anatomical repair in the neonate. Ann Thorac Surg (1984) 1.37

Unilateral pulmonary vein atresia: clinical and radiographic spectrum. Pediatr Cardiol (1983) 1.36

Pulmonary artery sling. J Thorac Cardiovasc Surg (1975) 1.35

Vascular structure in lung tissue obtained at biopsy correlated with pulmonary hemodynamic findings after repair of congenital heart defects. Circulation (1984) 1.34

Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation (1981) 1.34

Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol (2001) 1.33

Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol (1989) 1.33

Emergent, urgent, and elective admissions. Studies in a general hospital psychiatric emergency service. Arch Gen Psychiatry (1969) 1.30

First-stage palliation of hypoplastic left heart syndrome. The importance of coarctation and shunt size. J Thorac Cardiovasc Surg (1986) 1.30

Pulmonary valve-moderator band distance and association with development of double-chambered right ventricle. Am J Cardiol (1991) 1.27

Mitral valve replacement in the first year of life. J Thorac Cardiovasc Surg (1990) 1.27

Measurement of systemic and pulmonary blood flow and QP/QS ratio using Doppler and two-dimensional echocardiography. Am J Cardiol (1983) 1.26

In utero pulmonary artery and aortic growth and potential for progression of pulmonary outflow tract obstruction in tetralogy of Fallot. J Am Coll Cardiol (1995) 1.26

Open-heart surgery during the first three months of life. J Thorac Cardiovasc Surg (1974) 1.26

Diagnosis, transport, and outcome in fetuses with left ventricular outflow tract obstruction. J Thorac Cardiovasc Surg (1991) 1.24

Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest (1985) 1.24

Tetralogy of Fallot with obstruction of the ventricular septal defect: spectrum of echocardiographic findings. J Am Coll Cardiol (1988) 1.19

Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J Control Release (1998) 1.19

Extending the limits for modified Fontan procedures. J Thorac Cardiovasc Surg (1986) 1.19

The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children. Circulation (1974) 1.19

Double-chamber right ventricle: experience with 17 cases. Am Heart J (1975) 1.18

Utility of intraoperative transesophageal echocardiography in the assessment of residual cardiac defects. Pediatr Cardiol (1998) 1.18

Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J Biol Chem (1997) 1.17

Natural history and patterns of recovery of contractile function in single left ventricle after Fontan operation. Circulation (1992) 1.16

Fixed subaortic stenosis in the young: medical and surgical course in 83 patients. Am J Cardiol (1983) 1.16

Video-assisted thoracoscopic surgery for congenital heart disease. J Thorac Cardiovasc Surg (1995) 1.16

Bidirectional cavopulmonary anastomosis as interim palliation for high-risk Fontan candidates. Early results. Circulation (1990) 1.15

Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res (1999) 1.15

Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol (1992) 1.14

Long-term follow-up of patients with synthetic right heart conduits. Circulation (1985) 1.14

Enhanced plasmid DNA transfection with lysosomotropic agents in cultured fibroblasts. Int J Pharm (2001) 1.14

Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol (2000) 1.13

Immunoglobulins and left ventricular structure and function in pediatric HIV infection. Circulation (1995) 1.13

Al+++ binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model. ASAIO Trans (1990) 1.13

Experience with valved conduits for repair of congenital cardiac lesions. Ann Thorac Surg (1977) 1.12

Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol (1990) 1.12

Atherocalcin, a gamma-carboxyglutamic acid containing protein from atherosclerotic plaque. Biochem Biophys Res Commun (1979) 1.12

Diagnosis and management of infantile marfan syndrome. Pediatrics (1990) 1.12

Diagnosis of anomalous left coronary artery by Doppler color flow mapping: distinction from other causes of dilated cardiomyopathy. J Am Coll Cardiol (1992) 1.12